title: Anti-CD2O chimeric monoclonal antibody (rituximab) treatment of immune-mediated thrombocytopenia associated with Crohn's disease.
authors.forename: Konstantinos A
authors.initials: KA
authors.lastname: Papadakis
authors.forename: Barry
authors.initials: B
authors.lastname: Rosenbloom
authors.forename: Stephan R
authors.initials: SR
authors.lastname: Targan
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D003424:Crohn Disease / Q000150:complications* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007107:Immune System / Q000503:physiopathology*; D000069283:Rituximab; D013921:Thrombocytopenia / Q000209:etiology*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000069283:Rituximab